ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

86 filings reported holding PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share as of Q4 2021.
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 45.4M shares of 105M outstanding shares and own 43.13% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (7.03M shares), Privium Fund Management B.V. (4.77M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.72M shares), FMR LLC (4.46M shares), WELLINGTON MANAGEMENT GROUP LLP (4.02M shares), GOLDMAN SACHS GROUP INC (3.91M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2M shares), JENNISON ASSOCIATES LLC (1.81M shares), COWEN AND COMPANY, LLC (1.56M shares), and Opaleye Management Inc. (1.44M shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.